Cooper Elizabeth, Woolf Zoe, Swanson Molly E V, Correia Jason, Schweder Patrick, Mee Edward, Heppner Peter, Turner Clinton, Faull Richard L M, Scotter Emma L, Denny William A, Choi Peter J, Dragunow Mike, Jose Jiney, Park Thomas I-H
Department of Pharmacology, University of Auckland, Auckland, New Zealand.
Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.
Neurooncol Adv. 2022 Oct 14;4(1):vdac166. doi: 10.1093/noajnl/vdac166. eCollection 2022 Jan-Dec.
Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults. Whilst the role of the efflux transporters are well established in GBM, the expression and function of uptake transporters, such as the organic anion transporting polypeptide (OATP) family, are not well understood. OATPs possess broad substrate specificity that includes anti-cancer agents; therefore, we sought to investigate the expression of four OATP isoforms in human GBM cell types using patient tumor tissue.
We used fluorescent immunohistochemical labeling of paraffin-embedded surgically resected tissues and single-cell image analysis methods to explore the expression of the OATP isoforms in different tumor cell types through co-labeling with cell-type specific markers, such as IBA1 (pan-myeloid), GFAP (tumor cell), PDGFRβ (stromal cell), and UEA-1-lectin (endothelial).
We found significant over-expression of all the OATP isoforms (OATP1A2, 2B1, 1C1 and 4A1) in GBM tumor sections when compared to non-neoplastic brain. A single-cell image analysis revealed that OATPs were significantly upregulated throughout the tumor parenchyma, with significantly higher expression found on lectin-positive blood vessels and IBA1-positive myeloid cells in GBM compared to non-tumor brain tissue. Qualitative analysis of the four OATP isoforms demonstrated greater expression of OATP4A1 in peri-necrotic regions of GBM tissue, which correlated with hypoxia-related markers within the Ivy GAP RNAseq dataset.
Here, we demonstrate, for the first time, the protein expression of four OATPs in human GBM tissue, including upregulation within the tumor microenvironment by myeloid cells and tumor vasculature, and isoform-specific upregulation within hypoxic niches.
胶质母细胞瘤(GBM)是成人中最常见且侵袭性最强的原发性脑肿瘤。虽然外排转运蛋白在GBM中的作用已得到充分证实,但摄取转运蛋白的表达和功能,如有机阴离子转运多肽(OATP)家族,尚未得到充分了解。OATP具有广泛的底物特异性,包括抗癌药物;因此,我们试图使用患者肿瘤组织来研究四种OATP异构体在人GBM细胞类型中的表达。
我们使用石蜡包埋的手术切除组织的荧光免疫组织化学标记和单细胞图像分析方法,通过与细胞类型特异性标志物(如IBA1(全髓样细胞)、GFAP(肿瘤细胞)、PDGFRβ(基质细胞)和UEA-1凝集素(内皮细胞))共标记,来探索不同肿瘤细胞类型中OATP异构体的表达。
与非肿瘤性脑相比,我们发现GBM肿瘤切片中所有OATP异构体(OATP1A2、2B1、1C1和4A1)均有显著过表达。单细胞图像分析显示,整个肿瘤实质中OATP显著上调,与非肿瘤脑组织相比,GBM中凝集素阳性血管和IBA1阳性髓样细胞上的表达显著更高。对四种OATP异构体的定性分析表明,GBM组织坏死周边区域中OATP4A1的表达更高,这与Ivy GAP RNAseq数据集中的缺氧相关标志物相关联。
在此,我们首次证明了四种OATP在人GBM组织中的蛋白表达,包括髓样细胞和肿瘤脉管系统在肿瘤微环境中的上调,以及缺氧微环境中异构体特异性上调。